Skip to main content Skip to page footer
dkfz logo dkfz logo
Search

The Patient Research Council NCT West


The Patient Research Council NCT West was founded in 2023. Its six members are actively involved in developing and monitoring clinical trials at the NCT. The members have been affected by illness, either personally or through a family member or friend.

The following entities are covered by the Patient Research Council NCT West: malignant melanoma, multiple myeloma, rectal carcinoma, bile duct carcinoma, leukemia (in children), and sarcoma. 

Patient research councils are experienced patient representatives who have gained significant previous experience with advisory boards and assessing clinical studies and research projects.

Current dates:

The main areas of activity are:

  • Supporting researchers in optimizing clinical trials and other projects at the NCT West;
  • Working closely with the NCT West Board of Directors to advise on the further development of the site;
  • Promoting cooperation with self-help organizations, physicians, scientists, and institutions at the NCT West site.

Mike Butler

Co-speaker Campus Cologne; member of the CIO Cologne Patient Advisory Board

Dirk Hellrung

Co-speaker Campus Essen; member of the DKFZ Cancer Research Patient Advisory Board

Maximillian Heller

Campus Cologne; member of the CIO Cologne Patient Advisory Board

Thorsten Hilgers

Campus Cologne; member of the CIO Cologne Patient Advisory Board

 

Nicola Prasuhn

Campus Essen; member of the WTZ Patient Advisory Board

Markus Wartenberg

Campus Essen; spokesperson of the NCT Patient Research Council

Contact

Dr. Rhoda Wismer

Patient Involvement 
Campus Cologne
patientenbeteiligung-at-nct-west.de

Dr. Maria Josten

Patient Involvement 
Campus Essen
patientenbeteiligung-at-nct-west.de